- Home
- PNF vs BEAT Comparison
PNF vs BEAT Comparison
Compare PNF & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNF
- BEAT
- Stock Information
- Founded
- PNF 2001
- BEAT 2015
- Country
- PNF United States
- BEAT United States
- Employees
- PNF N/A
- BEAT N/A
- Industry
- PNF Finance Companies
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- PNF Finance
- BEAT Technology
- Exchange
- PNF Nasdaq
- BEAT Nasdaq
- Market Cap
- PNF 54.9M
- BEAT 51.1M
- IPO Year
- PNF N/A
- BEAT 2021
- Fundamental
- Price
- PNF N/A
- BEAT $0.95
- Analyst Decision
- PNF
- BEAT Buy
- Analyst Count
- PNF 0
- BEAT 1
- Target Price
- PNF N/A
- BEAT $8.00
- AVG Volume (30 Days)
- PNF 29.1K
- BEAT 74.4K
- Earning Date
- PNF 01-01-0001
- BEAT 08-13-2025
- Dividend Yield
- PNF 5.17%
- BEAT N/A
- EPS Growth
- PNF N/A
- BEAT N/A
- EPS
- PNF N/A
- BEAT N/A
- Revenue
- PNF N/A
- BEAT N/A
- Revenue This Year
- PNF N/A
- BEAT N/A
- Revenue Next Year
- PNF N/A
- BEAT N/A
- P/E Ratio
- PNF N/A
- BEAT N/A
- Revenue Growth
- PNF N/A
- BEAT N/A
- 52 Week Low
- PNF $6.37
- BEAT $0.95
- 52 Week High
- PNF $9.06
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- PNF 10.55
- BEAT 17.33
- Support Level
- PNF $6.68
- BEAT $1.24
- Resistance Level
- PNF $7.64
- BEAT $1.30
- Average True Range (ATR)
- PNF 0.05
- BEAT 0.07
- MACD
- PNF -0.40
- BEAT -0.02
- Stochastic Oscillator
- PNF 0.00
- BEAT 1.16
About PNF PIMCO New York Municipal Income Fund
PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.